Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 7, 2012, Pages 1203-1212

  Hvidtfeldt, Ulla A ^a   Gunter, Marc J ^c   Lange, Theis ^a   Chlebowski, Rowan T ^d   Lane, Dorothy ^e   Farhat, Ghada N ^g   Freiberg, Matthew S ^h   Keiding, Niels ^a   Lee, Jennifer S ⁱ   Prentice, Ross ^j   Tjønneland, Anne ^b   Vitolins, Mara Z ^k   Wassertheil Smoller, Silvia ^f   Strickler, Howard D ^f   Rod, Naja H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF BALAMAND   (Lebanon)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

^k WAKE FOREST SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; INSULIN;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CASE STUDY; COHORT ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; ALCOHOL DRINKING; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; UNITED STATES; WOMEN'S HEALTH;

EID: 84863585013     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0310     Document Type: Article

References (51)

1. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, et al. Alcohol and breast cancer in women - a pooled analysis of cohort studies. JAMA 1998;279:535-40. (Pubitemid 28113433)
2. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 1994;5:73-82. (Pubitemid 24066596)
3. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height,weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
4. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26. (Pubitemid 37069552)
5. Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, et al. Physical activity and breast cancer - a systematic review. Epidemiology 2007;18:137-57. (Pubitemid 46005918)
6. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, et al. Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002;87:1234-45.
7. McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, dams-Campbell LL, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women - The Women's Health Initiative cohort study. JAMA 2003;290:1331-6. (Pubitemid 37442629)
8. Dorgan JF, Longcope C, Franz C, Stanczyk FZ, Chang LC, Stephenson HE, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
9. Thomas HV, Reeves GK, Key TJA. Endogenous estrogen and postmenopausal breast cancer a quantitative review. Cancer Causes Control 1997;8:922-8. (Pubitemid 27485468)
10. Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, et al. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 2011;364:2381-91.
11. Rod NH, Hansen AM, Nielsen J, Schnohr P, Gronbaek M. Low-risk factor profile, estrogen levels, and breast cancer risk among postmenopausal women. Int J Cancer 2009;124:1935-40.
12. Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 2011;105:709-22.
13. Newcomb PA, Klein R, Klein BE, Haffner S, Mares-Perlman J, Cruickshanks KJ, et al. Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology 1995;6:318-21.
14. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297-302.
15. Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001;93:710-5. (Pubitemid 32492813)
16. Vatsalya V, Issa JE, Hommer DW, Ramchandani VA. Pharmacodynamic effects of intravenous alcohol on hepatic and gonadal hormones: influence of age and sex. Alcohol Clin Exp Res 2012;36:207-13.
17. Neilson HK, Friedenreich CM, Brockton NT, Millikan RC. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 2009;18:11-27.
18. Kendall A, Folkerd EJ, Dowsett M. Influences on circulating oestrogens in postmenopausal women: relationship with breast cancer. J Steroid Biochem Mol Biol 2007;103:99-109. (Pubitemid 46149297)
19. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
20. Coyle YM. Lifestyle, genes, and cancer. Methods Mol Biol 2009;472:25-56.
21. Lange T, Hansen JV. Direct and indirect effects in a survival context. Epidemiology 2011;22:575-81.
22. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13:S18-77. (Pubitemid 37324176)
23. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
24. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003;13:S5-17.
25. Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 2011;103:562-70.
26. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80. (Pubitemid 23027685)
27. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003;13:S122-8. (Pubitemid 37324181)
28. Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L, et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006;163:1053-64. (Pubitemid 43987598)
29. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
30. Kalbfleisch JD, Lawless JF. Likelihood analysis of multi-state models for disease incidence and mortality. Stat Med 1988;7:149-60. (Pubitemid 18045527)
31. SAS Institute Inc. The MI Procedure. SAS/STAT 9.22 user's guide. Cary, NC: SAS Institute Inc.; 2010.
32. Schafer JL. Analysis of incomplete multivariate data. 1st ed. New York, NY: Chapmann and Hall; 1997.
33. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc 1996;91:473-89.
34. Hafeman DM, Schwartz S. Opening the Black Box: a motivation for the assessment of mediation. Int J Epidemiol 2009;38:838-45.
35. Aalen OO. A model for non-parametric regression analysis of counting processes. In:Klonecki W, Kozek A, Rosinski J, editors. Lecture notes in statistics-2: mathematical statistics and probability theory. New York, NY: Springer-Verlag; 1980. p. 1-25.
36. Martinussen T, Scheike TH. Dynamic regression models for survival data. 1st ed. New York, NY: Springer-Verlag; 2006.
37. R version 2.10.1. [cited Dec 14 2009]. Available from: http://cran.rproject.org.
38. Rinaldi S, Key TJ, Peeters PH, Lahmann PH, Lukanova A, Dossus L, et al. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer 2006;118:2832-9. (Pubitemid 43673364)
39. Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. Cancer Epidemiol Biomarkers Prev 2005;14:1047-51. (Pubitemid 40656446)
40. Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study. J Natl Cancer Inst 2010;102:1422-31.
41. Suzuki R, Orsini N, Mignone L, Saji S, Wolk A. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis of epidemiological studies. Int J Cancer 2008;122:1832-41. (Pubitemid 351413431)
42. Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, et al. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol 2011;174:661-71.
43. Horwitz KB, Koseki Y, McGuire WL. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 1978;103:1742-51. (Pubitemid 9051866)
44. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-612. (Pubitemid 47106631)
45. Gavaler JS, Van Thiel DH. The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: relationship to the literature. Alcohol Clin Exp Res 1992;16:87-92.
46. Gavaler JS, Love K. Detection of the relationship between moderate alcoholic beverage consumption and serum levels of estradiol in normal postmenopausal women: effects of alcohol consumption quantitation methods and sample size adequacy. J Stud Alcohol 1992;53:389-94.
47. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-54.
48. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, et al. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 2009;125:2704-10.
49. Cole SR, Hernan MA. Fallibility in estimating direct effects. Int J Epidemiol 2002;31:163-5. (Pubitemid 34284920)
50. Kaufman JS, Maclehose RF, Kaufman S. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol Perspect Innov 2004;1:4.
51. WHI investigators. [cited 2012]. Available from: http://www.whiscience. org/publications/WHI-investigators-shortlist.pdf.